All Stories

  1. Usability of a Medication Event Reminder Monitor System (MERM) by Providers and Patients to Improve Adherence in the Management of Tuberculosis

    Article • International Journal of Environmental Research and Public Health, September 2017, MDPI AG

    Professor Terrence Blaschke

  2. Poor medication adherence in clinical trials: consequences and solutions

    Article • Nature Reviews Drug Discovery, February 2017, Springer Science + Business Media

    Professor Terrence Blaschke

  3. Introduction to the Theme “New Methods and Novel Therapeutic Approaches in Pharmacology and Toxicology”

    Article • The Annual Review of Pharmacology and Toxicology, January 2017, Annual Reviews

    Professor Terrence Blaschke

  4. Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations

    Article • Journal of the International AIDS Society, January 2017, Wiley

    Professor Terrence Blaschke

  5. Introduction to the Theme “Cancer Pharmacology”

    Article • The Annual Review of Pharmacology and Toxicology, January 2016, Annual Reviews

    Professor Terrence Blaschke, Professor Urs A Meyer

  6. Introduction to the Theme “Precision Medicine and Prediction in Pharmacology”

    Article • The Annual Review of Pharmacology and Toxicology, January 2015, Annual Reviews

    Professor Terrence Blaschke

  7. Adherence to Medications: Insights Arising from Studies on the Unreliable Link Between Prescribed and Actual Drug Dosing Histories

    Article • The Annual Review of Pharmacology and Toxicology, February 2012, Annual Reviews

    Professor Terrence Blaschke

  8. Integrative Continuum: Accelerating Therapeutic Advances in Rare Autoimmune Diseases

    Article • The Annual Review of Pharmacology and Toxicology, February 2012, Annual Reviews

    Professor Terrence Blaschke

  9. Risk of Fractures Requiring Hospitalization After an Initial Prescription for Zolpidem, Alprazolam, Lorazepam, or Diazepam in Older Adults

    Article • Journal of the American Geriatrics Society, September 2011, Wiley

    Professor Terrence Blaschke

  10. Understanding Forgiveness: Minding and Mining the Gaps Between Pharmacokinetics and Therapeutics

    Article • Clinical Pharmacology & Therapeutics, October 2010, Springer Science + Business Media

    Professor Terrence Blaschke

  11. Global Challenges for Clinical Pharmacology in the Developing World

    Article • Clinical Pharmacology & Therapeutics, June 2009, Springer Science + Business Media

    Professor Terrence Blaschke

  12. Variable adherence to prescribed dosing regimens for protease inhibitors: scope and outcomes

    Article • Current Opinion in HIV and AIDS, November 2008, Wolters Kluwer Health

    Professor Terrence Blaschke

  13. Increased Vascular ??1-Adrenergic Sensitivity in Patients With Renal Failure

    Article • American Journal of Therapeutics, September 2007, Wolters Kluwer Health

    Professor Terrence Blaschke

  14. Improving Data Reliability Using a Non-Compliance Detection Method versus Using Pharmacokinetic Criteria

    Article • Journal of Pharmacokinetics and Pharmacodynamics, September 2006, Springer Science + Business Media

    Professor Terrence Blaschke

  15. Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions

    Article • HIV Medicine, March 2006, Wiley

    Professor Terrence Blaschke

  16. Adherence to Medication

    Article • New England Journal of Medicine, November 2005, New England Journal of Medicine (NEJM/MMS)

    Professor Terrence Blaschke

  17. Adherence to Medication

    Article • New England Journal of Medicine, August 2005, New England Journal of Medicine (NEJM/MMS)

    Professor Terrence Blaschke

  18. The perils of public health by press release

    Article • The Lancet, September 2004, Elsevier

    Professor Terrence Blaschke

  19. SEXDIFFERENCES INPHARMACOKINETICS ANDPHARMACODYNAMICS

    Article • The Annual Review of Pharmacology and Toxicology, February 2004, Annual Reviews

    Professor Terrence Blaschke

  20. Protein Binding in Antiretroviral Therapies

    Article • AIDS Research and Human Retroviruses, September 2003, Mary Ann Liebert Inc

    Professor Terrence Blaschke

  21. Effect of simultaneous versus staggered dosing on pharmacokinetic interactions of protease inhibitors

    Article • Clinical Pharmacology & Therapeutics, May 2003, Springer Science + Business Media

    Professor Terrence Blaschke

  22. Model-based Analysis of the Pharmacokinetic Interactions Between Ritonavir, Nelfinavir, and Saquinavir after Simultaneous and Staggered Oral Administration

    Article • Drug Metabolism and Disposition, December 2002, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Professor Terrence Blaschke

  23. Position Paper on Therapeutic Drug Monitoring of Antiretroviral Agents

    Article • AIDS Research and Human Retroviruses, August 2002, Mary Ann Liebert Inc

    Professor Terrence Blaschke

  24. Determination of nelfinavir free drug concentrations in plasma by equilibrium dialysis and liquid chromatography/tandem mass spectrometry: important factors for method optimization

    Article • European Journal of Pharmaceutical Sciences, March 2002, Elsevier

    Professor Terrence Blaschke

  25. Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047

    Article • AIDS, March 2002, Wolters Kluwer Health

    Professor Terrence Blaschke

  26. Role of nitric oxide in isoprenaline and sodium nitroprusside-induced relaxation in human hand veins

    Article • British Journal of Clinical Pharmacology, December 2001, Wiley

    Professor Terrence Blaschke

  27. Effect of liver disease on dose optimization

    Article • International Congress Series, August 2001, Elsevier

    Professor Terrence Blaschke

  28. Optimizing the Science of Drug Development: Opportunities for Better Candidate Selection and Accelerated Evaluation in Humans

    Article • The Journal of Clinical Pharmacology, August 2000, Wiley

    Professor Terrence Blaschke

  29. Optimizing the science of drug development: opportunities for better candidate selection and accelerated evaluation in humans

    Article • European Journal of Pharmaceutical Sciences, June 2000, Elsevier

    Professor Terrence Blaschke

  30. Heparin-induced vasodilation in human hand veins*

    Article • Clinical Pharmacology & Therapeutics, September 1999, Springer Science + Business Media

    Professor Terrence Blaschke

  31. Pharmacokinetics of intravenous and oral L‐arginine in normal volunteers

    Article • British Journal of Clinical Pharmacology, March 1999, Wiley

    Professor Terrence Blaschke

  32. Pharmacokinetics of L-arginine during chronic administration to patients with hypercholesterolaemia

    Article • Clinical Science, February 1999, Portland Press Ltd.

    Professor Terrence Blaschke

  33. Inhibition of angiotensin-converting enzyme in human hand veins

    Article • Clinical Pharmacology & Therapeutics, January 1999, Springer Science + Business Media

    Professor Terrence Blaschke

  34. Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial

    Article • AIDS, November 1998, Wolters Kluwer Health

    Professor Terrence Blaschke

  35. The extent of non-adherence in a large AIDS clinical trial using plasma dideoxynucleoside concentrations as a marker

    Article • AIDS, November 1998, Wolters Kluwer Health

    Professor Terrence Blaschke

  36. A Markov mixed effect regression model for drug compliance

    Article • Statistics in Medicine, October 1998, Wiley

    Professor Terrence Blaschke

  37. DRUGS AND THE LIVER; HEART FAILURE

    Article • British Journal of Clinical Pharmacology, October 1998, Wiley

    Professor Terrence Blaschke

  38. Chloroquine-induced venodilation in human hand veins*

    Article • Clinical Pharmacology & Therapeutics, June 1997, Springer Science + Business Media

    Professor Terrence Blaschke

  39. Article • Journal of Pharmacokinetics and Biopharmaceutics, January 1997, Springer Science + Business Media

    Professor Terrence Blaschke

  40. Pharmacokinetics of high-dose oral CCNU in bone marrow transplant patients

    Article • Cancer Chemotherapy and Pharmacology, August 1996, Springer Science + Business Media

    Professor Terrence Blaschke

  41. Do we need full compliance data for population pharmacokinetic analysis?

    Article • Journal of Pharmacokinetics and Biopharmaceutics, June 1996, Springer Science + Business Media

    Professor Terrence Blaschke

  42. Introducing medical students to medication noncompliance*

    Article • Clinical Pharmacology & Therapeutics, May 1996, Nature

    Professor Terrence Blaschke

  43. High-Performance Liquid Chromatographic Assay for the Quantitation of l -Arginine in Human Plasma

    Article • Analytical Chemistry, January 1996, American Chemical Society (ACS)

    Professor Terrence Blaschke

  44. Intra-subject variation and individual difference of Zidovudine phosphorylation in human peripheral blood submerged monocyte.

    Article • Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, January 1996, Japanese Society of Clinical Pharmacology and Therapeutics

    Professor Terrence Blaschke

  45. Clinical Pharmacokinetics of Rifabutin

    Article • Clinical Pharmacokinetics, February 1995, Springer Science + Business Media

    Professor Terrence Blaschke

  46. Effects of smoking on vascular reactivity.Evaluation by dorsal hand vein technique.

    Article • Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, January 1995, Japanese Society of Clinical Pharmacology and Therapeutics

    Professor Terrence Blaschke

  47. Plasma ddC concentration measurements method by combining extraction, concentration by immobilized phase and RIA.

    Article • Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, January 1995, Japanese Society of Clinical Pharmacology and Therapeutics

    Professor Terrence Blaschke

  48. Histamine-induced venodilation in human beings involves both H1 and H2 receptor subtypes

    Article • Journal of Allergy and Clinical Immunology, March 1994, Elsevier

    Professor Terrence Blaschke

  49. Venodilation in Raynaud's disease

    Article • The Lancet, December 1993, Elsevier

    Professor Terrence Blaschke

  50. Zidovudine response relationships in early human immunodeficiency virus infection

    Article • Clinical Pharmacology & Therapeutics, November 1993, Springer Science + Business Media

    Professor Terrence Blaschke

  51. Glutathione S-transferase μ polymorphism does not explain variation in nitroglycerin responsiveness

    Article • Clinical Pharmacology & Therapeutics, April 1993, Springer Science + Business Media

    Professor Terrence Blaschke

  52. Primum non nocere? Valuing of the risk of drug toxicity in therapeutic decision making

    Article • Clinical Pharmacology & Therapeutics, March 1993, Springer Science + Business Media

    Professor Terrence Blaschke

  53. Mechanism of Bradykinin-Induced Venodilation in Humans

    Article • Journal of Cardiovascular Pharmacology, February 1993, Wolters Kluwer Health

    Professor Terrence Blaschke

  54. Desensitization of Nitrate-Induced Venodilation: Reversal with Oral N-Acetylcysteine in Humans

    Article • Journal of Cardiovascular Pharmacology, December 1992, Wolters Kluwer Health

    Professor Terrence Blaschke

  55. Comparison of vasodilatory responses to nitroglycerin and its dinitrate metabolites in human veins

    Article • Clinical Pharmacology & Therapeutics, December 1992, Springer Science + Business Media

    Professor Terrence Blaschke

  56. Analysis of free intracellular nucleotides using high-performance capillary electrophoresis

    Article • Analytical Chemistry, August 1992, American Chemical Society (ACS)

    Professor Terrence Blaschke

  57. Desensitization of β-Adrenoceptor– and Prostaglandin E1 Receptor–Mediated Human Vascular Smooth Muscle Relaxation

    Article • Journal of Cardiovascular Pharmacology, March 1992, Wolters Kluwer Health

    Professor Terrence Blaschke

  58. Advanced computer programs for drug dosing that combine pharmacokinetic and symbolic modeling of patients

    Article • Computers and Biomedical Research, February 1992, Elsevier

    Professor Terrence Blaschke

  59. Age-related changes in adenosine and beta-adrenoceptor responsiveness of vascular smooth muscle in man.

    Article • British Journal of Clinical Pharmacology, January 1992, Wiley

    Professor Terrence Blaschke

  60. Incorporating Pharmacokinetic/Pharmacodynamic Modeling in Drug Development—Are We Ready?

    Article • Drug Information Journal, January 1992, SAGE Publications

    Professor Terrence Blaschke

  61. Vascular reactivity to phenylephrine and angiotensin II: Comparison of direct venous and systemic vascular responses

    Article • Clinical Pharmacology & Therapeutics, January 1992, Springer Science + Business Media

    Professor Terrence Blaschke

  62. Phenobarbital does not increase early labeling of bilirubin from 4-[14C]-δ-aminolevulinic acid in man and rat

    Article • Hepatology, December 1991, Wiley

    Professor Terrence Blaschke

  63. Responsiveness of peripheral veins to vasodilators and the effect of nifedipine on α-adrenergic responsiveness in hypertension

    Article • Clinical Pharmacology & Therapeutics, August 1991, Springer Science + Business Media

    Professor Terrence Blaschke

  64. Decreased Responsiveness of Superficial Hand Veins to Phenylephrine in Black Normotensive Males

    Article • Journal of Cardiovascular Pharmacology, August 1990, Wolters Kluwer Health

    Professor Terrence Blaschke

  65. Gentamicin pharmacokinetics in neonates undergoing extracorporal membrane oxygenation

    Article • The Pediatric Infectious Disease Journal, August 1990, Wolters Kluwer Health

    Professor Terrence Blaschke

  66. Dose-dependent inhibition of cyclosporine metabolism in mice by fluconazole

    Article • Canadian Journal of Physiology and Pharmacology, January 1990, Canadian Science Publishing

    Professor Terrence Blaschke

  67. Effect of temazepam on blood pressure regulation in healthy elderly subjects.

    Article • British Journal of Clinical Pharmacology, January 1990, Wiley

    Professor Terrence Blaschke

  68. Nifedipine pharmacokinetics during preterm labor tocolysis

    Article • American Journal of Obstetrics and Gynecology, December 1989, Elsevier

    Professor Terrence Blaschke

  69. Clinical pharmacology comes of age

    Article • Clinical Pharmacology & Therapeutics, November 1989, Nature

    Professor Terrence Blaschke

  70. Responsiveness of Peripheral Veins to Transdermal and Sublingual Nitroglycerin in Healthy Male Volunteers

    Article • Journal of Cardiovascular Pharmacology, October 1989, Wolters Kluwer Health

    Professor Terrence Blaschke

  71. Improving drug dosing in hospitalized patients: automated modeling of pharmacokinetics for individualization of drug dosage regimens

    Article • Computer Methods and Programs in Biomedicine, October 1989, Elsevier

    Professor Terrence Blaschke

  72. Pharmacokinetics of rifabutin.

    Article • Antimicrobial Agents and Chemotherapy, August 1989, ASM Journals

    Professor Terrence Blaschke

  73. Effects of ketoconazole on the polymorphic 4-hydroxylations of S- mephenytoin and debrisoquine.

    Article • British Journal of Clinical Pharmacology, August 1989, Wiley

    Professor Terrence Blaschke

  74. Evaluation of the Antiviral Effect of Rifabutin in AIDS-Related Complex

    Article • The Journal of Infectious Diseases, June 1989, Oxford University Press (OUP)

    Professor Terrence Blaschke

  75. Responsiveness of superficial hand veins to adrenergic stimuli in patients with cystic fibrosis

    Article • Clinical Science, March 1989, Portland Press Ltd.

    Professor Terrence Blaschke

  76. Theophylline toxicity subsequent to ranitidine administration: A possible drug-drug interaction

    Article • The American Journal of Medicine, January 1989, Elsevier

    Professor Terrence Blaschke

  77. A Message from the President - Come to Nashville, March 8-10, 1989

    Article • Clinical Pharmacology & Therapeutics, January 1989, Springer Science + Business Media

    Professor Terrence Blaschke

  78. Responsiveness of superficial hand veins to phenylephrine in essential hypertension. Alpha adrenergic blockade during prazosin therapy.

    Article • Journal of Clinical Investigation, January 1989, American Society for Clinical Investigation

    Professor Terrence Blaschke

  79. Venous responsiveness to atrial natriuretic factor in man.

    Article • British Journal of Clinical Pharmacology, December 1988, Wiley

    Professor Terrence Blaschke

  80. A Note from the President

    Article • Clinical Pharmacology & Therapeutics, July 1988, Springer Science + Business Media

    Professor Terrence Blaschke

  81. Effect of Etomidate on Hepatic Drug Metabolism in Humans

    Article • Anesthesiology, June 1988, Wolters Kluwer Health

    Professor Terrence Blaschke

  82. Etomidate Inhibits Antipyrine Metabolism in Mice

    Article • The American Journal of the Medical Sciences, June 1987, Elsevier

    Professor Terrence Blaschke

  83. Plasma antipyrine half-life can be determined from urine data.

    Article • British Journal of Clinical Pharmacology, June 1987, Wiley

    Professor Terrence Blaschke

  84. PHARMACODYNAMICS OF CYCLOSPORINE-KETOCONAZOLE INTERACTION IN MICE

    Article • Transplantation, April 1987, Wolters Kluwer Health

    Professor Terrence Blaschke

  85. In vivo interaction of the enantiomers of disopyramide in human subjects

    Article • Journal of Pharmacokinetics and Biopharmaceutics, August 1986, Springer Science + Business Media

    Professor Terrence Blaschke

  86. Electrophysiology of the Enantiomers of Disopyramide in Dogs

    Article • Journal of Cardiovascular Pharmacology, September 1985, Wolters Kluwer Health

    Professor Terrence Blaschke

  87. Discrepancies Between Pharmacokinetic Studies of Amitriptyline

    Article • Clinical Pharmacokinetics, January 1985, Springer Science + Business Media

    Professor Terrence Blaschke

  88. Measurement of antipyrine half-life from urinary drug concentrations [letter]

    Article • British Journal of Clinical Pharmacology, October 1984, Wiley

    Professor Terrence Blaschke

  89. Effect of Concentration-Dependent Binding to Plasma Proteins on the Pharmacokinetics and Pharmacodynamics of Disopyramide

    Article • Clinical Pharmacokinetics, January 1984, Springer Science + Business Media

    Professor Terrence Blaschke

  90. Dexamethasone Decreases Plasma Protein Binding of Prazosin In Vivo in Rabbits

    Article • Clinical Pharmacokinetics, January 1984, Springer Science + Business Media

    Professor Terrence Blaschke

  91. High-performance liquid chromatographic analysis of hypoxanthine arabinoside in plasma

    Article • Journal of Chromatography B Biomedical Sciences and Applications, January 1984, Elsevier

    Professor Terrence Blaschke

  92. Pharmacokinetic Interaction of Single Doses of Quinine and Digoxin in Dogs

    Article • Pharmacology, January 1984, Karger Publishers

    Professor Terrence Blaschke

  93. Effect of Heparin on the Red Blood Cell-to-Plasma Concentration Ratio of Diphenylhydantoin and Prazosin

    Article • Therapeutic Drug Monitoring, December 1983, Wolters Kluwer Health

    Professor Terrence Blaschke

  94. Clinical Pharmacists and the Undereducated Physician

    Article • New England Journal of Medicine, November 1983, New England Journal of Medicine (NEJM/MMS)

    Professor Terrence Blaschke

  95. Amitriptyline disposition in young and elderly normal men

    Article • Journal of Clinical Psychopharmacology, October 1983, Wolters Kluwer Health

    Professor Terrence Blaschke

  96. Effect of low doses of heparin on the plasma binding of phenytoin and prazosin in normal man

    Article • European Journal of Clinical Pharmacology, August 1983, Springer Science + Business Media

    Professor Terrence Blaschke

  97. The Undereducated Physician's Therapeutic Decisions

    Article • New England Journal of Medicine, June 1983, New England Journal of Medicine (NEJM/MMS)

    Professor Terrence Blaschke

  98. Amitriptyline disposition in young and elderly normal men

    Article • Clinical Pharmacology & Therapeutics, March 1983, Springer Science + Business Media

    Professor Terrence Blaschke

  99. Calculation of drug concentration in plasma after equilibrium dialysis.

    Article • British Journal of Clinical Pharmacology, November 1982, Wiley

    Professor Terrence Blaschke

  100. High-Pressure Liquid Chromatographic Determination of Amitriptyline and Its Major Metabolites in Human Whole Blood

    Article • Journal of Pharmaceutical Sciences, May 1982, Elsevier

    Professor Terrence Blaschke

  101. Growth hormone release after acute amitriptyline administration to normal human subjects

    Article • Psychopharmacology, March 1982, Springer Science + Business Media

    Professor Terrence Blaschke

  102. The cardiac effects of disopyramide isomers

    Article • The American Journal of Cardiology, March 1982, Elsevier

    Professor Terrence Blaschke

  103. Measurement of ketoconazole, a new antifungal agent, by high-performance liquid chromatography

    Article • Journal of Chromatography B Biomedical Sciences and Applications, February 1982, Elsevier

    Professor Terrence Blaschke

  104. The effect of saturable binding to plasma proteins on the pharmacokinetic properties of disopyramide

    Article • Journal of Pharmacokinetics and Biopharmaceutics, February 1982, Springer Science + Business Media

    Professor Terrence Blaschke

  105. Disposition of ketoconazole, an oral antifungal, in humans.

    Article • Antimicrobial Agents and Chemotherapy, January 1982, ASM Journals

    Professor Terrence Blaschke

  106. Furosemide Disposition in Cirrhotic Patients

    Article • Gastroenterology, December 1981, Elsevier

    Professor Terrence Blaschke

  107. Vitamin K1, vitamin K1 epoxide and warfarin interrelationships in the dog

    Article • Biochemical Pharmacology, November 1981, Elsevier

    Professor Terrence Blaschke

  108. Synthesis and anticholinergic properties of the enantiomers of 4-(isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide, the mono-N-dealkylated metabolite of disopyramide

    Article • Journal of Medicinal Chemistry, May 1981, American Chemical Society (ACS)

    Professor Terrence Blaschke

  109. Effect of naloxone, a specific opioid inhibitor, on blood pressure fall during sleep.

    Article • Circulation, January 1981, Wolters Kluwer Health

    Professor Terrence Blaschke

  110. Absence of effect of heparin on the binding of prazosin and phenytoin to plasma proteins

    Article • Biochemical Pharmacology, December 1980, Elsevier

    Professor Terrence Blaschke

  111. Administration of heparin causes release of non-esterified fatty acids in human plasma

    Article • Life Sciences, September 1980, Elsevier

    Professor Terrence Blaschke

  112. Comparative anticholinergic potencies of R- and S- disopyramide in longitudinal muscle strips from guinea pig ileum

    Article • Life Sciences, September 1980, Elsevier

    Professor Terrence Blaschke

  113. Studies on the clinical pharmacology of prazosin. I: Cardiovascular, catecholamine and endocrine changes following a single dose.

    Article • British Journal of Clinical Pharmacology, July 1980, Wiley

    Professor Terrence Blaschke

  114. Studies on the clinical pharmacology of prazosin. II: The influence of indomethacin and of propranolol on the action and disposition of prazosin.

    Article • British Journal of Clinical Pharmacology, July 1980, Wiley

    Professor Terrence Blaschke

  115. Prazosin protein binding in health and disease.

    Article • British Journal of Clinical Pharmacology, February 1980, Wiley

    Professor Terrence Blaschke

  116. Saliva and plasma levels and plasma protein binding of clofibrinic acid in uremic patients

    Article • Clinical Pharmacology & Therapeutics, February 1980, Springer Science + Business Media

    Professor Terrence Blaschke

  117. Prazosin First-Pass Metabolism and Hepatic Extraction in the Dog

    Article • Journal of Cardiovascular Pharmacology, November 1979, Wolters Kluwer Health

    Professor Terrence Blaschke

  118. Measurement of furosemide by high-performance liquid chromatography

    Article • Journal of Chromatography A, July 1979, Elsevier

    Professor Terrence Blaschke

  119. Enhanced Bioavailability and Decreased Clearance of Analgesics in Patients with Cirrhosis

    Article • Gastroenterology, July 1979, Elsevier

    Professor Terrence Blaschke

  120. Influence of congestive heart failure on prazosin kinetics

    Article • Clinical Pharmacology & Therapeutics, June 1979, Wiley

    Professor Terrence Blaschke

  121. NALOXONE LOWERS PLASMA-PROLACTIN IN MAN

    Article • The Lancet, June 1979, Elsevier

    Professor Terrence Blaschke

  122. Atenolol determination by high-performance liquid chromatography and fluorescence detection

    Article • Journal of Chromatography A, April 1979, Elsevier

    Professor Terrence Blaschke

  123. Plasma catecholamines in man are not influenced by the inhibition of prostaglandin synthesis

    Article • Prostaglandins, April 1979, Elsevier

    Professor Terrence Blaschke

  124. Hepatic First-pass Metabolism in Liver Disease

    Article • Clinical Pharmacokinetics, January 1979, Springer Science + Business Media

    Professor Terrence Blaschke

  125. Probenecid inhibition of methotrexate excretion from cerebrospinal fluid in dogs

    Article • Journal of Pharmacokinetics and Biopharmaceutics, October 1978, Springer Science + Business Media

    Professor Terrence Blaschke

  126. VITAMIN K1 DISPOSITION AND THERAPY OF WARFARIN OVERDOSE

    Article • The Lancet, October 1978, Elsevier

    Professor Terrence Blaschke

  127. Effect of phenobarbitone on the disposition of lignocaine and warfarin in the dog*

    Article • Journal of Pharmacy and Pharmacology, September 1978, Wiley

    Professor Terrence Blaschke

  128. Gas chromatographic analysis of pentazocine

    Article • Journal of Chromatography A, July 1978, Elsevier

    Professor Terrence Blaschke

  129. Interaction of clofibrate with warfarin. I. Effect of clofibrate on the disposition of the optical enantiomorphs of warfarin

    Article • Journal of Pharmacokinetics and Biopharmaceutics, October 1977, Springer Science + Business Media

    Professor Terrence Blaschke

  130. High-pressure liquid chromatographic analysis of drugs in biological fluids

    Article • Journal of Chromatography A, July 1977, Elsevier

    Professor Terrence Blaschke

  131. Influence of acute viral hepatitis on disposition and plasma binding of tolbutamide

    Article • Clinical Pharmacology & Therapeutics, March 1977, Wiley

    Professor Terrence Blaschke

  132. Protein Binding and Kinetics of Drugs in Liver Diseases

    Article • Clinical Pharmacokinetics, February 1977, Springer Science + Business Media

    Professor Terrence Blaschke

  133. Application of Salivary Concentration Data to Pharmacokinetic Studies with Antipyrine

    Article • Journal of Pharmaceutical Sciences, January 1977, Elsevier

    Professor Terrence Blaschke

  134. High-Pressure Liquid Chromatographic Analysis of drugs in Biological Fluids I: Warfarin

    Article • Journal of Pharmaceutical Sciences, January 1977, Elsevier

    Professor Terrence Blaschke

  135. Influence of viral hepatitis on the disposition of two compounds with high hepatic clearance: Lidocaine and indocyanine green

    Article • Clinical Pharmacology & Therapeutics, September 1976, Wiley

    Professor Terrence Blaschke

  136. Influence of acute viral hepatitis on disposition and pharmacologic effect of warfarin

    Article • Clinical Pharmacology & Therapeutics, July 1976, Wiley

    Professor Terrence Blaschke

  137. Differences between the Plasma Indocyanine Green Disappearance Rates of Normal Men and Women

    Article • Experimental Biology and Medicine, December 1975, SAGE Publications

    Professor Terrence Blaschke

  138. Influence of acute viral hepatitis on phenytoin kinetics and protein binding

    Article • Clinical Pharmacology & Therapeutics, June 1975, Wiley

    Professor Terrence Blaschke

  139. Drugs and the liver—I

    Article • Biochemical Pharmacology, October 1974, Elsevier

    Professor Terrence Blaschke

  140. Effect of Induced Fever on Sulfobromophthalein Kinetics in Man

    Article • Annals of Internal Medicine, February 1973, American College of Physicians

    Professor Terrence Blaschke

  141. Augmentation of Bilirubin UDP Glucuronyltransferase Activity in Rat Liver Homogenates by Glutethimide

    Article • Experimental Biology and Medicine, September 1972, SAGE Publications

    Professor Terrence Blaschke

  142. Pharmacokinetics: Absorption, Distribution, Metabolism, Excretion Overview Chapter

    Article • Cambridge University Press

    Professor Terrence Blaschke